Cullinan Associates’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,838
Closed -$680K 241
2023
Q3
$680K Buy
7,838
+490
+7% +$44.3K 0.04% 165
2023
Q2
$695K Hold
7,348
0.04% 175
2023
Q1
$555K Buy
7,348
+300
+4% +$22.6K 0.03% 183
2022
Q4
$542K Buy
+7,048
New +$536K 0.03% 196
2022
Q2
Sell
-7,579
Closed -$430K 230
2022
Q1
$430K Sell
7,579
-4,000
-35% -$214K 0.02% 187
2021
Q4
$596K Hold
11,579
0.03% 171
2021
Q3
$573K Buy
11,579
+42
+0.4% +$2.28K 0.03% 171
2021
Q2
$659K Buy
+11,537
New +$674K 0.04% 156

Other funds holding CAH

Cullinan Associates's CAH Position: Q4 2023 in Review

Cullinan Associates sold out of Cardinal Health (CAH) in Q4 2023, closing a stake of 7,838 shares — an estimated $680K sold.

Cullinan Associates first reported a position in CAH in Q2 2021 and held it in 8 quarters. The position peaked at $695K in Q2 2023. 1,037 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

  • Cullinan Associates reported no remaining Cardinal Health position as of Q4 2023 after selling out during the quarter.
  • Cullinan Associates sold 7,838 Cardinal Health shares in Q4 2023, an estimated $680K.
  • Cullinan Associates first reported a position in Cardinal Health in Q2 2021 and held it in 8 quarters.
  • Cullinan Associates's Cardinal Health position peaked at $695K in Q2 2023.
  • 1,037 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on Cullinan Associates's 13F filing for Q4 2023, filed 24 Jan 2024.